Profiel
Sarah Connors worked as a Media Contact at AMAG Pharmaceuticals, Inc. and as a Vice President-Corporate Communications at Karyopharm Therapeutics, Inc.
Eerdere bekende functies van Sarah Connors
| Bedrijven | Functie | Einde |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Public Communications Contact | 01-03-2023 |
| AMAG PHARMACEUTICALS, INC. | Public Communications Contact | 01-06-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
